James Brugarolas

James Brugarolas

University of Texas Southwestern Medical Center

H-index: 58

North America-United States

About James Brugarolas

James Brugarolas, With an exceptional h-index of 58 and a recent h-index of 43 (since 2020), a distinguished researcher at University of Texas Southwestern Medical Center, specializes in the field of Kidney cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Magnetic resonance imaging radiomics analyses for prediction of high-grade histology and necrosis in clear cell renal cell carcinoma: preliminary experience

Complement as prognostic biomarker and potential therapeutic target in renal cell carcinoma

Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC)(RADVAX RCC).

The von Hippel-Lindau tumor suppressor gene: implications and therapeutic opportunities

HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma

De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma

Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer

James Brugarolas Information

University

Position

___

Citations(all)

16690

Citations(since 2020)

7028

Cited By

12478

hIndex(all)

58

hIndex(since 2020)

43

i10Index(all)

111

i10Index(since 2020)

100

Email

University Profile Page

University of Texas Southwestern Medical Center

Google Scholar

View Google Scholar Profile

James Brugarolas Skills & Research Interests

Kidney cancer

Top articles of James Brugarolas

Title

Journal

Author(s)

Publication Date

Magnetic resonance imaging radiomics analyses for prediction of high-grade histology and necrosis in clear cell renal cell carcinoma: preliminary experience

Clinical genitourinary cancer

Durgesh K Dwivedi

Yin Xi

Payal Kapur

Ananth J Madhuranthakam

Matthew A Lewis

...

2021/2/1

Complement as prognostic biomarker and potential therapeutic target in renal cell carcinoma

The Journal of Immunology

Britney Reese

Ashok Silwal

Elizabeth Daugherity

Michael Daugherity

Mahshid Arabi

...

2020/12/1

Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC)(RADVAX RCC).

Hans J Hammers

Dendra Vonmerveldt

Chul Ahn

Rosa Maria Nadal

Charles G Drake

...

2020/2/20

The von Hippel-Lindau tumor suppressor gene: implications and therapeutic opportunities

Roy Elias

Qing Zhang

James Brugarolas

2020/9/1

HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma

Clinical Cancer Research

Kevin D Courtney

Yuanqing Ma

Alberto Diaz de Leon

Alana Christie

Zhiqun Xie

...

2020/2/15

De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection

Science translational medicine

Daria Beshnova

Jianfeng Ye

Oreoluwa Onabolu

Benjamin Moon

Wenxin Zheng

...

2020/8/19

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma

Journal for Immunotherapy of Cancer

Viral Patel

Roy Elias

Joseph Formella

William Schwartzman

Alana Christie

...

2020

Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer

Michele Carbone

J William Harbour

James Brugarolas

Angela Bononi

Ian Pagano

...

2020/8/1

Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type

EBioMedicine

Qi Cai

Alana Christie

Satwik Rajaram

Qinbo Zhou

Ellen Araj

...

2020/1/1

Pancreatic tropism of metastatic renal cell carcinoma

JCI insight

Nirmish Singla

Zhiqun Xie

Ze Zhang

Ming Gao

Qurratulain Yousuf

...

2020/4/4

The evolution of angiogenic and inflamed tumors: the renal cancer paradigm

Cancer cell

James Brugarolas

Satwik Rajaram

Alana Christie

Payal Kapur

2020/12/14

Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes

Science immunology

Tianshi Lu

Shidan Wang

Lin Xu

Qinbo Zhou

Nirmish Singla

...

2020/2/21

See List of Professors in James Brugarolas University(University of Texas Southwestern Medical Center)

Co-Authors

H-index: 106
Ralph DeBerardinis

Ralph DeBerardinis

University of Texas Southwestern Medical Center

H-index: 104
Nick Grishin

Nick Grishin

University of Texas Southwestern Medical Center

H-index: 36
Xuewu Zhang

Xuewu Zhang

University of Texas Southwestern Medical Center

academic-engine